Navigation Links
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Date:5/14/2008

es to build momentum as a global scientific force and will soon emerge as a coordinated commercial effort to develop innovative therapies for patients afflicted with diseases from genetic maladies to cancer to neuromuscular and metabolic disorders," said Grayson, Fate's new president and CEO. "The opportunity to build an entirely new model for a biotechnology company is tremendously exciting, and we have the people, vision and backing to do it."

"At Fate we see a new field of medicines emerging with our proprietary therapeutic engine - renewal therapies," said Dr. Mendlein, executive chairman of Fate Therapeutics. "We aim to leverage our strong scientific foundation to accelerate our fundamental understanding of cellular fate in multiple disease and physiological settings to generate innovative therapeutics for those in need. We are in the throes of making revolutionary connections between the molecular basis of cell fate, human medical conditions and important medicines of the future. Our fresh insights into cell fate give us optimism that our drugs will potentially interact with human physiology in a better, safer fashion."

Paul Grayson was previously managing director of Sanderling Ventures. Over the last ten years he has completed both private and public capital fundraising, delivering over $200 million for emerging companies. Transactions completed under Grayson's watch produced over $150 million in recognizable revenue with an announceable value in excess of $1 billion dollars, and included agreements with BMS, Lilly, Warner Lambert, Merck, F. Hoffmann La Roche, Pharmacia Upjohn, Kraft Foods, Campbell's Soup, Nestle and the Coca Cola Company. Grayson was a founding member of the management team of Aurora Biosciences and the founding chairman, CEO and president of Senomyx, Inc. He was previously chairman of the board of directors for Naviscan PET Systems and CalciMedica, and active on the board of directors for Taligen Therapeutics and REN Pharmac
'/>"/>

SOURCE Fate Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
2. Amicus Therapeutics Announces First Quarter 2008 Financial Results
3. Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
4. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
5. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
6. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
7. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
8. President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
9. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
10. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
11. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , September 23, 2014 ... from Imperial Innovations, Cambridge Innovation Capital and Johnson ... clinical cancer genomics company focused on harnessing the ... improve cancer testing and treatment, today announced it ... by Imperial Innovations and including Cambridge Innovation Capital ...
(Date:9/22/2014)... YORK and SANTA CLARA, Calif. ... Corp. (NASDAQ: WBMD ), the leading source ... new WebMD/Medscape survey that provide novel insights ... in aiding diagnosis and care.  Dr. Eric Topol ... and digital medicine, who serves as both Editor-in-Chief of ...
(Date:9/22/2014)... fragments whose job it is to stop bleeding, are ... they can "feel" the physical environment around them, researchers ... respond to surfaces with greater stiffness by increasing their ... platelets and other components of the clotting system, the ... them credit for, in that they are able to ...
(Date:9/22/2014)... University of Minnesota electrical engineering researchers have developed ... time demonstrates mechanical transportation of light. The discovery ... more efficient optical devices for computation and communication. ... electrical and computer engineering assistant professor Mo Li ... published online and will appear in the October ...
Breaking Biology Technology:Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 2WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 3WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 4Platelets modulate clotting behavior by 'feeling' their surroundings 2Engineers show light can play seesaw at the nanoscale 2
... April 20 Shire plc (LSE: SHP,NASDAQ: SHPGY ), the global ... , , Results press release will be issued at: ... Investor conference call time: ... EDT, , Live conference call for investors: , ...
... Mass. April 20 Advanced Instruments, ... Multi-Sample Osmometer as the first true automation-friendly osmometer ... Multi-Sample Osmometer is specifically designed for ... osmolality testing in the biopharmaceutical laboratory," said Kelly ...
... Inc., a development-stage pharmaceutical company discovering and developing ... James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, ... at this year,s American Society for Pharmacology and ... place from April 18-22, 2009 in New Orleans. ...
Cached Biology Technology:Shire plc: First Quarter 2009 Results Date Notification - April 30, 2009 2Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry 2Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry 3Quark Pharmaceuticals to Present at American Society for Pharmacology and Experimental Therapeutics Annual Meeting 2Quark Pharmaceuticals to Present at American Society for Pharmacology and Experimental Therapeutics Annual Meeting 3
(Date:9/23/2014)... EdmontonCleaning up oil sands tailings has just gotten a ... University of Alberta civil engineering professors that uses solar ... , Instead of using UV lamps as a light ... retained in tailings ponds, professors Mohamed Gamal El-Din and ... a renewable energy source treats the wastewater just as ...
(Date:9/23/2014)... more carbon than the atmosphere and small changes ... effect on atmospheric greenhouse gas concentrations. A new ... concludes that climate warming does not accelerate ... storage, despite increases in ecosystem productivity. , ... Ecologist Dr. Christian Giardina, with the agency,s Institute ...
(Date:9/23/2014)... West Orange, NJ. September 23, 2014. Kessler Foundation ... of a foot drop stimulator during a task-specific ... system. This finding indicates that applying the foot ... from this common complication of stroke. "EMG of ... utilization of a foot drop stimulator," was published ...
Breaking Biology News(10 mins):Solar energy-driven process could revolutionize oil sands tailings reclamation 2Study helps assess impact of temperature on belowground soil decomposition 2
... Consumers shouldn,t assume that, because a product is ... University of Guelph study reveals some organic pesticides ... pesticides because the organic product may require larger ... PhD candidate Christine Bahlai compared the effectiveness and ...
... that governs flower formation has been uncovered in the daisy-like ... BMC Plant Biology have published a pair of articles ... this process differs from other model plants, such as the ... Teeri, from the University of Helsinki, Finland, worked with a ...
... been puzzled by the ability of microscopic algae to grow ... essential algal nutrient. In this week,s issue of Nature, ... Riser at the University of Washington and David Karl at ... from deep water, as much as 250 meters below the ...
Cached Biology News:Organic pesticides not always 'greener' choice, study finds 2Researchers discover source of essential nutrients for mid-ocean algae 2Researchers discover source of essential nutrients for mid-ocean algae 3
... clone d1-174 GenBank Accession Number : ... N-terminal tagged fusion protein corresponding to full ... Tris-glycine, pH 7.4, 0.15M NaCl, 0.05% sodium ... 30% Quality Assurance: routinely evaluated by immunoblot ...
Rat CXCL7/Thymus Chemokine-1 DuoSet Economy Pack, 45 Plate...
Recombinant Rat Fas Ligand/TNFSF6...
FGF Receptor 1 Antibody...
Biology Products: